FDG PET For Myocardial Viability Gains Positive Coverage Decision From CMS

FDG positron emission tomography's high specificity in determining myocardial viability following revascularization establishes the technology's value as a stand-alone diagnostic, according to a Feb. 20 1national coverage decision issued by CMS